Ethnic variations in the distribution of obesity and biochemical metabolic abnormalities in fertility clinic attendees

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 53, Issue 2, 2008, Pages 117-123

  Palep Singh, Manisha ^a   Picton, Helen M ^b   Barth, Julian H ^b   Balen, Adam H ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

Diabetes mellitus; Ethnic groups; Female; Infertility; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROL GROUP; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; FEMALE FERTILITY; HUMAN; HYPERINSULINEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; WAIST CIRCUMFERENCE; ASIAN; CAUCASIAN; COMPARATIVE STUDY; ETHNOLOGY; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; METABOLIC SYNDROME X; OBESITY; POLYCYSTIC OVARY SYNDROME;

EID: 44049084400     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. World Health Organization: WHO Recommendation: Obesity: Preventing and Managing the Global Epidemic. Geneva, WHO, 2000
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Final report. Circulation 2002;106:3143-3421
3. Brewer HB Jr: Rising to the challenge of the new NCEP ATP III guidelines: Exceeding current therapeutic limitations (suppl 2) 2002;8:S23-S28
4. Carnethon MR, Loria CM, Hill JO, et al: Coronary artery risk development in young adults study: Risk factors for the metabolic syndrome: The Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004;27:2707-2715
5. Keller KB, Lemberg L: Obesity and the metabolic syndrome. Am J Crit Care 2003;12:167-170
6. Appel SJ, Harrell JS, Davenport ML: Central obesity, the metabolic syndrome and PAI-1 in young adults. J Am Acad Nurse Pract 2005;17:535-541
7. Soysal A, Demiral Y, Soysal D, et al: The prevalence of metabolic syndrome among young adults in Izmir, Turkey (abstr). Anadolu Kardiyol Derg 2005;5:196-201
8. Talbott E, Guzick D, Clerici A, et al: Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vase Biol 1995;15:821-826
9. Balen AH, Conway GS, Kaltsas G, et al: Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-2111
10. McKeigue PM, Shah B, Marmot MG: Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-386
11. McKeigue PM, Ferrie JE, Pierpoint T, et al: Association of early onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993; 87:152-161
12. Dokras A, Bochner M, Hollinrake E, et al: Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131-137
13. Vrbikova J, Vondra K, Cibula D, et al: Metabolic syndrome in young Czech women with polycystic ovary syndrome. Hum Reprod 2005;20:3328-3332
14. Shah T, Jonnalagadda SS, Kicklighter JR, et al: Prevalence of metabolic syndrome risk factors among young adult Asian Indians. J Immigr Health 2005;7:117-126
15. Balarajan R: Ethnicity and variations in mortality for CHD. Health Trends 1996;28:45-51
16. Wilkinson P, Sayer J, Laji K, et al: Comparison of case fatality in South Asians and white patients after acute myocardial infarction: An observational study. BMJ 1996;312:1330-1333
17. Wijeyaratne C, Balen AH, Barth JH, et al: Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference? Clin Endocrinol 2002;57:343-350
18. Mulders AG, Eijkemans MJ, Imani B, et al: Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome (PCOS): The Rotterdam/ ASRM-sponsored PCOS Consensus Workshop Group. Hum Reprod 2004;19:41-47, Fertil Steril 2004;81:19-25
19. Lai SW, Ng KC: Overall obesity and abdominal obesity and the risk of metabolic abnormalities. Ir J Med Sci 2004;173: 193-196
20. WHO/IASO/IOTF: The Asia-Pacific perspective: Redefining obesity and its treatment. 2000. Health Communications, Australia PTY Ltd. Available at http://www.diabetes.com. au/pdf/obesity_report.pdf. Accessed 2006
21. Visser M, Bouter LM, McQuillan GM, et al: Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-2135
22. Samad F, Pandey M, Loskutoft DJ: Tissue factor gene expression in the adipose tissue of obese mice. Proc Natl Acad Sci USA 1998;95:7591-7596
23. Wolk R, Berger P, Lennon RJ, et al: Body mass index: A risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 2003;108:2206-2211
24. Harjai K: Potential new cardiovascular risk factors: Left ventricular hypertrophy, homocysteine, lipoprotein (a), triglyceride, oxidative stress and fibrinogen. Ann Intern Med 1999; 131:376-386
25. Sarkar S, Das M, Mukhopadhyay B, et al: Prevalence of metabolic syndrome in 2 tribal populations of the sub Himalayan region of India: Ethnic, rural and urban differences. Am J Hum Biol 2005;17:814-817
26. Misra KB, Endemann SW, Ayer M: Leisure time physical activity and metabolic syndrome in Asian Indian immigrants residing in Northern California. Eth Dis 2005;15:627-634
27. Wild S, Pierpoint T, McKeigue P, et al: Cardiovascular disease in women with polycystic ovary syndrome at long term follow up: A retrospective cohort study. Clin Endocrinol (Oxf) 2000;52:595-600
28. Rabelo Acevedo M, Vick MR: Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico. P R Health Sci J 2005;24:203-206
29. Chambers JC, Obeid OA, Refsum H, et al: Plasma homocysteine concentrations and risk of coronary heart disease in the UK Indian Asians and European men. Lancet 2000;355:523-527
30. Bellamy MF, McDowell IF, Ramsey MW, et al: Hyperhomocysteinemia after an oral Methionine load acutely impairs endothelial function in healthy adults. Circulation 1998;98: 1848-1852
31. Beauchamp M-C, Renier G: Homocysteine induces protein kinase C activation and stimulates c-Fos and lipoprotein lipase expression in the macrophages. Diabetes 2002;51:1180-1187
32. Bastard JP, Pieroni L: Plasma plasminogen activator inhibitor-1, insulin resistance and android obesity. Biomed Pharmacother 1999;53:455-461
33. Davi G, Guagnano MT, Ciabattoni G: Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA 2002;288:2008-2014
34. Devaraj S, Xu DY, Jialal I: C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: Implications for the metabolic syndrome and atherothrombosis. Circulation 2003;107: 398-404
35. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: Risk marker or mediator in atherothrombosis? Hypertension 2004;44:6-11
36. Garcia-Lorda P, Bullo M, Balanza R, et al: C reactive protein, adiposity and cardiovascular risk factors in a Mediterranean population. Int J Obes (Lond) 2006;30:468-474
37. Bellosta S, Via D, Canavesi M: HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages. Arterioscler Thromb Vase Biol 1998;18:1671-1678
38. Ridker PM, Cushman M, Stampfer MJ, et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979